XERIS BIOPHARMA HOLDINGS, INC. (XERS) ROI
- 2026-06-30: ROI -7.07%.
- 2025-12-31: ROI 0.24%.
- 2025-09-30: ROI -7.15%.
- 2025-06-30: ROI -16.05%.
Complete source-backed roi history.
- Available history
- 2023-12-31 to 2026-06-30
- Data captured
Historical ROI
| Date | ROI |
|---|---|
| 2026-06-30 | -7.07% |
| 2025-12-31 | 0.24% |
| 2025-09-30 | -7.15% |
| 2025-06-30 | -16.05% |
| 2025-03-31 | -23.16% |
| 2024-12-31 | -27.08% |
| 2024-09-30 | -31.10% |
| 2023-12-31 | -33.81% |
Annual ROI
| Date | ROI |
|---|---|
| 2025-12-31 | 0.24% |
| 2024-12-31 | -27.08% |
| 2023-12-31 | -33.81% |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Stoke Therapeutics, Inc. (STOK) | United States | $1.630B | -9.82 |
| Rapport Therapeutics, Inc. (RAPP) | United States | $1.623B | -14.56 |
| Syndax Pharmaceuticals Inc (SNDX) | United States | $1.606B | -8.82 |
| Eton Pharmaceuticals, Inc. (ETON) | United States | $1.701B | 80.74 |
| Kailera Therapeutics, Inc. (KLRA) | United States | $1.552B | |
| ANAPTYSBIO, INC (ANAB) | United States | $1.546B | -60.20 |
| Innoviva, Inc. (INVA) | United States | $1.493B | 4.62 |
| Xencor Inc (XNCR) | United States | $1.776B | -7.33 |
| ArriVent BioPharma, Inc. (AVBP) | United States | $1.485B | -10.25 |
| Septerna, Inc. (SEPN) | United States | $1.783B | -63.01 |